Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised

Journal of Clinical Virology

Volumn 53, Issue 4, 2012, Pages 346-349

  Maylin, Sarah ^a   Stephan, Robin ^a   Molina, Jean Michel ^a   Peraldi, Marie Noelle ^a   Scieux, Catherine ^a   Nicand, Elisabeth ^b   Simon, François ^a   Delaugerre, Constance ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b University of Paris Descartes   (France)

Author keywords

Antibodies; Genome; HEV; Immunocompromised; Paris; Urban area

Indexed keywords

ALANINE AMINOTRANSFERASE; GENOMIC RNA; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; FRANCE; HEPATITIS E; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROPREVALENCE; SURGICAL PATIENT;

ADULT; COHORT STUDIES; FEMALE; GENOME, VIRAL; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, CHRONIC; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PARIS; PREVALENCE; RNA, VIRAL; URBAN POPULATION;

EID: 84858160166     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.01.001     Document Type: Article

References (27)

1. Emerson S.U., Purcell R.H. Hepatitis E virus. Rev Med Virol 2003, 13:145-154.
2. Huang F.F., Sun Z.F., Emerson S.U., Purcell R.H., Shivaprasad H.L., Pierson F.W., et al. Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol 2004, 85:1609-1618.
3. Dalton H.R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8:698-709.
4. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. New Engl J Med 2008, 358:811-817.
5. Ollier L., Tieulie N., Sanderson F., Heudier P., Giordanengo V., Fuzibet J.G., et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009, 150:430-431.
6. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. New Engl J Med 2009, 361:1025-1027.
7. Kaba M., Richet H., Ravaux I., Moreau J., Poizot-Martin I., Motte A., et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011, 83:1704-1716.
8. Kenfak-Foguena A., Schoni-Affolter F., Burgisser P., Witteck A., Darling K.E., Kovari H., et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011, 17:1074-1078.
9. Renou C., Moreau X., Pariente A., Cadranel J.F., Maringe E., Morin T., et al. A national survey of acute hepatitis E in France. Aliment Pharmacol Ther 2008, 27:1086-1093.
10. Enouf V., Dos Reis G., Guthmann J.P., Guerin P.J., Caron M., Marechal V., et al. Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens. J Med Virol 2006, 78:1076-1082.
11. Cooper K., Huang F.F., Batista L., Rayo C.D., Bezanilla J.C., Toth T.E., et al. Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J Clin Microbiol 2005, 43:1684-1688.
12. Borgen K., Herremans T., Duizer E., Vennema H., Rutjes S., Bosman A., et al. Non-travel related hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004-2006. BMC Infect Dis 2008, 8:61.
13. Lewis H.C., Boisson S., Ijaz S., Hewitt K., Ngui S.L., Boxall E., et al. Hepatitis E in England and Wales. Emerg Infect Dis 2008, 14:165-167.
14. Wichmann O., Schimanski S., Koch J., Kohler M., Rothe C., Plentz A., et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008, 198:1732-1741.
15. Clemente-Casares P., Pina S., Buti M., Jardi R., MartIn M., Bofill-Mas S., et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003, 9:448-454.
16. Meng X.J., Wiseman B., Elvinger F., Guenette D.K., Toth T.E., Engle R.E., et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002, 40:117-122.
17. Olsen B., Axelsson-Olsson D., Thelin A., Weiland O. Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis 2006, 38:55-58.
18. Widdowson M.A., Jaspers W.J., van der Poel W.H., Verschoor F., de Roda Husman A.M., et al. Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands. Clin Infect Dis 2003, 36:29-33.
19. Boutrouille A., Bakkali-Kassimi L., Cruciere C., Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007, 45:2009-2010.
20. Mansuy J.M., Legrand-Abravanel F., Calot J.P., Peron J.M., Alric L., Agudo S., et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008, 80:289-293.
21. Renou C., Lafeuillade A., Cadranel J.F., Pavio N., Pariente A., Allegre T., et al. Hepatitis E virus in HIV-infected patients. Aids 2010, 24:1493-1499.
22. Khan A., Tanaka Y., Kurbanov F., Elkady A., Abbas Z., Azam Z., et al. Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol 2011, 83:622-629.
23. Kamar N., Abravanel F., Selves J., Garrouste C., Esposito L., Lavayssiere L., et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010, 89:353-360.
24. Madejon A., Vispo E., Bottecchia M., Sanchez-Carrillo M., Garcia-Samaniego J., Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009, 16:895-896.
25. Kikuchi K., Yoshida T., Kimata N., Sato C., Akiba T. Prevalence of hepatitis E virus infection in regular hemodialysis patients. Ther Apher Dial 2006, 10:193-197.
26. Kamar N., Garrouste C., Haagsma E.B., Garrigue V., Pischke S., Chauvet C., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011, 140:1481-1489.
27. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Garrouste C., Dubois M., Mansuy J.M., et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010, 202:835-844.